Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients

Completed · Not applicable

Conditions studied: Pharmacogenetic Testing

In brief

This is a pragmatic clinical trial of 100 patients who self-identify as black or Latino. Patients with active prescriptions for at least 3 medications and a medication change within the past 6-months will be recruited from the University of Florida (UF) Health primary care clinics for panel-based pharmacogenetic testing. Participants will be followed for 6 months and will undergo assessments with the Treatment Satisfaction Questionnaire for Medication (TSQM) three times (baseline visit, 3-month visit, and 6-month visit post pharmacogenetic testing). In addition, data on effectiveness outcomes and socioeconomic measures will be collected via the electronic health record (EHR) and patient report. Participation is expected to last approximately 6 months and the study will be open for approximately 12-14 months.

Key facts

Study ID

NCT04630093

Run by

University of Florida

People needed

100

Starts

2021-05-13

Expected to finish

2022-06-22

Last updated by the study team

2023-10-04

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (18 years or older) with active prescriptions for at least 3 medications documented within the EHR.
• At least 1 drug/drug class that could be informed by the pharmacogenetics test panel available at the UF.
• A medication change within the past 6 months (associated with a healthcare provider encounter).
• Self-identify as black or Latino.

You may not qualify if…

• Patients with any history of pharmacogenetic testing within the EHR.

Where it is running

• UF Health at the University of Florida — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.